Article Text


Basic science: Cardiovascular disease basic research
e0093 Myocardial infarction-induced remodelling and inflammatory cytokines in rats are attenuated by AVE0991
  1. Zeng Wutao,
  2. Chen Weiyan,
  3. Leng Xiuyu,
  4. Li Cuiling,
  5. Lin Hong,
  6. Dai Gang
  1. Division of Cardiology, Cardiovascular Medical Department, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China


Objective To investigate the effects of 4-week treatment with the nonpeptide angiotensin-(1-7) analogue AVE 0991 on expression of inflammatory cytokines and remodelling induced by myocardial infarction (MI).

Methods In this study, MI was induced by left coronary artery ligation in male Sprague-Dawley (SD) rats. After 4 weeks of treatment, the heart wet weight was recorded, normalised for body weight. Left ventricle serial sections were dyed with triphenyltetrazolium chloride (TTC) stain to quantify the infarct size, with Masson's trichrome stain to quantify collagen volume fraction (CVF), and with haematoxylin-eosin (HE) stain for diameter measurement of cardiomyocytes. RT-PCR was used to investigate the synthesis of TGF-β1, TNF-α, collagen type I and III.

Results Infarct size was slightly reduced in AVE 0991 group compared to control group (42.6±3.6% vs 50.9±4.4%, p<0.01). In addition, AVE 0991 reduced MI-induced hypertrophy as quantified by diameter measurements of cardiomyocytes (vs. control group 25.49±4.37 μm vs 32.06±6.85 μm, p<0.05). The overexpression of TGF-β1 and TNF-α mRNA were inhibited by chronic AVE 0991 treatment alone (vs. control group, TGF-β1: 4.15±1.18 vs 14.23±3.84, p<0.05; TNF-α: 2.21±0.44 vs 3.87±0.55, p<0.05, respectively). AVE 0991 markedly attenuated the increase of the expression of Collagen I (1.79±0.15 vs 4.3±0.75, p<0.001) and III (3.12±0.42 vs 9.55±0.83, p<0.001) mRNA compared to control group.

Conclusion The nonpeptide angiotensin-(1-7) analogue AVE 0991 could attenuate overexpression of inflammatory cytokines and ventricular remodelling induced by myocardial infarction (MI).

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.